Hoth Therapeutics to Attend BIO CEO and Investor Conference, February 26-27, 2024

Rhea-AI Summary

Hoth Therapeutics, Inc. (HOTH) CEO to attend BIO CEO and Investor Conference in New York, NY.

NEW YORK, Feb. 13, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Robb Knie, Chief Executive Officer, is scheduled to attend the BIO CEO and Investor Conference in New York, NY. 

To learn more about BIO CEO and Investor Conference please visit https://bcic.bio.org/.

About Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders. Hoth's pipeline has the potential to improve the quality of life for patients suffering from indications including atopic dermatitis, chronic wounds, psoriasis, asthma, and acne. Hoth has also recently entered into two different agreements to further the development of two different vaccine prospects to prevent or treat COVID-19. To learn more, please visit https://ir.hoththerapeutics.com/.

Investor Contact:
LR Advisors LLC 
Email: investorrelations@hoththerapeutics.com
www.hoththerapeutics.com
Phone: (678) 570-6791

View original content to download multimedia:https://www.prnewswire.com/news-releases/hoth-therapeutics-to-attend-bio-ceo-and-investor-conference-february-26-27-2024-302060867.html

SOURCE Hoth Therapeutics, Inc.

FAQ

When is the BIO CEO and Investor Conference taking place in New York, NY?

The BIO CEO and Investor Conference is scheduled to take place in New York, NY.

Who is the Chief Executive Officer of Hoth Therapeutics, Inc.?

Robb Knie is the Chief Executive Officer of Hoth Therapeutics, Inc.

What is the ticker symbol for Hoth Therapeutics, Inc.?

The ticker symbol for Hoth Therapeutics, Inc. is HOTH.

What event is Hoth Therapeutics, Inc. participating in?

Hoth Therapeutics, Inc. is participating in the BIO CEO and Investor Conference in New York, NY.